Gigantomastia — The Medical Condition

What Is Gigantomastia?

Gigantomastia (also called macromastia in less severe cases) is a medical condition characterised by abnormal, excessive breast tissue growth beyond normal variation. The condition has no universally agreed definition threshold, but is typically considered when breast tissue weighs 3% or more of total body weight, or where the growth causes significant functional impairment. It can develop during puberty (virginal gigantomastia), during pregnancy (gestational gigantomastia, which may resolve post-partum or persist), or in association with certain medications or other hormonal triggers.

Causes and Mechanisms

The exact mechanism of gigantomastia is not fully understood. Proposed causes include: increased sensitivity of breast tissue to oestrogen or progesterone; elevated hormone levels during specific hormonal transition periods; autoimmune components in some cases; and genetic predisposition. Gestational gigantomastia appears to be triggered by the extreme hormonal changes of pregnancy in susceptible individuals. Some medications (particularly certain antihypertensives and immunosuppressants) have been associated with gigantomastia-like growth.

Health Consequences

Severe gigantomastia causes significant health problems: extreme back, neck, and shoulder pain from weight and postural loading; skin breakdown, rash, and chronic infection in the breast fold and under-breast areas; respiratory compromise from chest wall compression in the most severe cases; nerve compression with numbness and weakness in the arms; and severe limitation of physical activity and daily function. These are genuine medical conditions that impair quality of life substantially.

Treatment Options

Breast reduction surgery (reduction mammaplasty) is the primary definitive treatment for gigantomastia. It is typically covered by insurance when medical necessity is documented — which it clearly is in genuine gigantomastia cases. Reduction provides significant health improvement in most patients. In gestational gigantomastia, medical management (hormone blocking agents) may be attempted first to halt progression; surgical intervention is often still required for complete treatment. Recurrence after reduction has been documented in some cases, particularly gestational gigantomastia.